Skip to main content
logo
R&G PharmaStudies Co., Ltd. (SHE:301333)
China flag China · Delayed Price · Currency is CNY
70.01
-0.63 (-0.89%)
Jan 22, 2026, 4:00 PM EST

Revenue by Product

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Clinical Trial Operation
319.97M
Log In
Log In
Log In
Log In
Upgrade
Clinical Trial Operation Growth
-9.74%
Log In
Log In
Log In
Log In
Upgrade
Clinical Trial Site Management
204.73M
Log In
Log In
Log In
Log In
Upgrade
Clinical Trial Site Management Growth
10.19%
Log In
Log In
Log In
Log In
Upgrade
Data Management and Statistical Analysis
100.68M
Log In
Log In
Log In
Log In
Upgrade
Data Management and Statistical Analysis Growth
26.35%
Log In
Log In
Log In
Log In
Upgrade
Biological Sample Testing
63.51M
Log In
Log In
Log In
Log In
Upgrade
Biological Sample Testing Growth
74.09%
Log In
Log In
Log In
Log In
Upgrade
Clinical Pharmacology
32.21M
Log In
Log In
Log In
Log In
Upgrade
Clinical Pharmacology Growth
-10.74%
Log In
Log In
Log In
Log In
Upgrade
Clinical Trial Consulting
22.91M
Log In
Log In
Log In
Log In
Upgrade
Clinical Trial Consulting Growth
-20.56%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
China
664.58M
Log In
Log In
Log In
Log In
Upgrade
China Growth
-1.45%
Log In
Log In
Log In
Log In
Upgrade
Overseas
79.42M
Log In
Log In
Log In
Log In
Upgrade
Overseas Growth
69.04%
Log In
Log In
Log In
Log In
Upgrade